Patient-Paired sample congruence between 2 commercial liquid biopsy tests

JAMA Oncology

Volumn 4, Issue 6, 2018, Pages 868-870

  Torga, Gonzalo ^a   Pienta, Kenneth J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CELL FREE DNA; DNA; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; CELL FREE NUCLEIC ACID;

ALK GENE; ANALYTICAL PARAMETERS; ATM GENE; CANCER STAGING; CLINICAL ARTICLE; COHORT ANALYSIS; EXON; FUSION GENE; GENE; GENE AMPLIFICATION; GENE MUTATION; HORMONE BLOOD LEVEL; HUMAN; INDEL MUTATION; LETTER; LIQUID BIOPSY; MALE; METASTATIC PROSTATE CANCER; NEXT GENERATION SEQUENCING; POINT MUTATION; PROSTATE CANCER; RELIABILITY; SAMPLE CONGRUENCE; SENSITIVITY AND SPECIFICITY; TUMOR GENE; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; BLOOD; COMPARATIVE STUDY; DNA MUTATIONAL ANALYSIS; DNA SEQUENCE; GENETICS; PROCEDURES; PROSTATE TUMOR; REPRODUCIBILITY;

ADENOCARCINOMA; CELL-FREE NUCLEIC ACIDS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; EXONS; GENES, NEOPLASM; HUMANS; LIQUID BIOPSY; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 85049728043     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2017.4027     Document Type: Letter

References (6)

1. Wan JCM, Massie C, Garcia-Corbacho J, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017;17(4): 223-238.
2. Webb S. The cancer bloodhounds. Nat Biotechnol. 2016;34(11):1090-1094.
3. Schwaederle M, Husain H, Fanta PT, et al. Use of liquid biopsies in clinical oncology: pilot experience in 168 patients. Clin Cancer Res. 2016;22(22):5497-5505.
4. Lanman RB, Mortimer SA, Zill OA, et al. Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA. PLoS One. 2015;10(10):e0140712.
5. Leary RJ, Sausen M, Kinde I, et al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med. 2012;4(162):162ra154.
6. Tannock IF, Hickman JA. Limits to personalized cancer medicine. N Engl J Med. 2016;375(13):1289-1294.